The Safety of Nasal Allergen Challenge Test Assessed in Lower Airways
,
Abstract
The aim of the study was to assess the safety of nasal allergen challenge, and the use of certain parameters applied in assessing the condition of the respiratory system. We enrolled 30 patients diagnosed with allergy to common environmental allergens and 30 healthy controls. The safety of nasal challenge tests with an allergen was assessed by measuring the concentration of exhaled nitric oxide from the lower respiratory tract (eNO) and forced expiratory volume in one second (FEV1) in a spirometry test. In the early phase of the allergic reaction, extra-nasal symptoms were observed, namely cough and breathlessness. These measured symptoms using the VAS scale, were far more frequent in the patients diagnosed with perennial allergic rhinitis. The eNO and FEV1 values in the spirometry test did not show any statistically significant changes. No correlation was observed between the breathlessness and cough complaints to the eNO concentration levels (cough: r=0.019, p=0.921; breathlessness: r=-0.088, p=0.644) nor the FEV1 level (cough: r=0.002, p=0.983; breathlessness: r=-0.072, p=0.751) in the spirometry test. In the early phase of the allergic reaction, nasal allergen challenge do not cause any significant changes in the lower airways, as measured with the use of certain parameters applied in assessing the function of the lower airways’ function.
1. Bousquet J, Khalataev N, Alvaro A, Denburg J, Fokkens W, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy 2008; (63 Suppl 86):8-60.
2. Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson N Jr, Meyers DA, Norman PS et al.: Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983; 128:597-602.
3. Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB.: Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol 1988; 82: 869-77.
4. Busse WW, Sedgwick JB. Eosinophil eicosanoid relations in allergic inflammation of the airways. Adv. Prostaglandin Thromboxane Leukot Res 1994; 22: 241-49.
5. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB.Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995; 12:477-87.
6. Shaw RJ, Fitzharris P, Cromwell O, Wardlaw AJ, Kay AB. Allergen-induced release of sulphidopeptide leukotrienes (SRS-A) and LTB4 in allergic rhinitis. Allergy 1985; 40:1-6.
7. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Bagnasco M, Canonica GW. Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena. Am J Respir Crit Care Med 1994; 150:1653-9.
8. Tuskan TC, Gemicioglu B, Ikitimur H, Yilmaz N, Tuskan K, Ferhan O, et al. The value and safety of specific nasal provocation in the diagnosis of allergic rhinitis in mild persistent asthma under inhaled steroid therapy. Asian Pac J Allergy Immunol 2010; 28:115-21.
9. Blair H. Natural history of childhood asthma: 20-year follow-up. Arch Dis Child 1997; 52(8):613-9.
10. Settipane GA. Allergic rhinitis-update. Otolaryngology Head Neck Surg 1986; 94(4):470-5.
11. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005; 171(8):912-30.
12. Andersson M, Greiff L, Svensson C, Persson C. Various methods for testing nasal responses in vivo: a critical review. Acta Otolaryngol 1995; 115(6):705-13.
13. Baki A, Ucar B. Diagnostic value of nasal provocation test with Dermatophagoides pteronyssinus in childhood asthma. Allergy 1995; 50(9):751-4.
14. Downie SR, Andersson M, Rimmer J, Leuppi JD, Xuan W, Akerlund A, et al. Association between nasal and bronchial symptoms In subjects with persistent allergic rhinitis. Allergy 2004; 59:320-6.
15. Yan K, Salome C. The response of the airways to nasal stimulation in asthmatic with rhinitis. Eur J Resp Dis 1983; 128(Pt 1):105-9.
16. Kirmaz C, Degirmenci P B, Tunali D, Yuksel H. Lower respiratory tract complications during nasal provocation: nonspecific stimulant or specific allergen? Ann Allergy Asthma Immunol 2007; 98(6):524-32.
17. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992; 89(2):611-8.
18. Baki A, Ucar B. Diagnostic value of nasal provocation test with Dermatophagoides pteronyssinus in childhood asthma. Allergy 1995; 50(9):751-4.
19. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A.Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998;101(5):581-6.
20. Alonso-Llamazares A, Martinez-Cócera C, Domínguez- Ortega J, Robledo-Echarren T, Cimarra-Alvarez M, Mesa del Castillo M. Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA). Allergy 2002; 57(7):632-5.
21. Kharitonov SA, Rajakulasingam K, O’Connor B, Durham SR, Barnes PJ. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 1997;99(1 pt 1):58-64.
22. Korn S, Beier J, Heilmann Ch, Kornmann O, Buhl R, Beeh M K. Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions. Respir Med 2005; 99(12):1595-9.
23. Gratziou C, Lignos M, Dassiuo M, Ruossos C. Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Respir J 1999; 14(4):897-901.
24. Lopuhaä CE, Koopmas JG, Jansen HM, Van Der Zee SJ.Similar levels of nitric oxide in non-asthmatic and rhinitis and asthma after bronchial allergen challenge. Allergy 2003; 58(4):300-5.
25. Bardin PG, Van Heerden BB, Joubert JR. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol 1990;86(1):82-8.
26. Beeh KM, Beier J, Kornmann O, Meier C, Taeumer T, Buhl R. A single nasal alergen challenge increases induced sputum inflammatory markers In non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy 2003; 33(4):475-82.
| Files | ||
| Issue | Vol 14, No 6 (2015) | |
| Section | Original Article(s) | |
| Keywords | ||
| Nitric oxide Nasal allergen challenge Safety assessment Spirometry | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
